Snake venom serine proteinases (SVSPs) are hemostatically active toxins that perturb the maintenance and regulation of both the blood coagulation cascade and fibrinolytic feedback system at specific points, and hence, are widely used as tools in pharmacological and clinical diagnosis. The crystal structure of a thrombin-like enzyme (TLE) from Bothrops jararacussu venom (Jararacussin-I) was determined at 2.48 Å resolution. This is the first crystal structure of a TLE and allows structural comparisons with both the Agkistrodon contortrix contortrix Protein C Activator and the Trimeresurus stejnegeri plasminogen activator. Despite the highly conserved overall fold, significant differences in the amino acid compositions and three-dimensional conformations of the loops surrounding the active site significantly alter the molecular topography and charge distribution profile of the catalytic interface. In contrast to other SVSPs, the catalytic interface of Jararacussin-I is highly negatively charged, which contributes to its unique macromolecular selectivity.
Hemostasis, a complex, intricate, and highly regulated system, is primed and orchestrated by the necessity of maintaining the delicate balance between coagulation and fibrinolysis. The majority of the enzymes involved in this system belong to the serine proteinase superfamily, which include plasmin, kallikrein, urokinase-like plasminogen activator (uPA), tissue factor-like plasminogen activator (tPA), and the multi-functional enzyme, thrombin.1 Thrombin can either stimulate coagulation or suppress upstream events in the blood coagulation cascade by depleting factor Va.2–6
Snake venoms are rich sources of hemostatically active toxins (HATs) that perturb both the blood coagulation cascade and fibrinolytic feedback system at specific points.7 HATs are typically, highly specific serine proteinases and rely on sophisticated molecular mechanisms, to activate or deplete coagulation factors such as fibrinogen (thrombin-like enzymes [TLEs]7), protein C (protein C activators9) and plasminogen (plasminogen activators8). Although TLEs such as the plasminogen and PC activators share significant sequence identity (50–70%), their high specificity toward different macromolecular targets results in different physiological responses in the hemostatic system.
Since snake venom TLEs share significant sequence identity with mammalian thrombin (around 30%) and the catalytic triad consisting of His57-Asp102-Ser195 is strictly conserved,11 their amidolytic activity profiles and subsite specificities are similar. These enzymes are widely referred to as TLEs due to their ability to mimic the procoagulant activity of thrombin by catalyzing the hydrolysis of fibrinopeptides α or β (rarely both) from fibrinogen (factor I), resulting in the formation of a soft clot.11–14 TLEs are potentially relevant and possess therapeutical and clinical applications and those isolated from Calloselasma rhodostoma and Bothrops atrox are commercially available and are used for diagnosis and clinical tests.15 TLEs are clinically interesting and have been tested as defibrinogenating agents for the treatment of patients with severe cardiovascular disorders. To date, a number of TLEs have been functionally characterized from snake venoms7, 15–27; however none of their three-dimensional structures have been determined. So far, only a protein C activator and a plasminogen activator have been structurally characterized and the determination of a TLE structure represents an important step in order to delineate the structural and molecular basis for snake venom serine proteinases (SVSPs) selectivity.
Here, we describe the first snake venom TLE structure revealing a catalytic interface with a highly negative electrostatic potential, which probably contributes to the observed macromolecular selectivity in targeting the enzyme to fibrinogen.
Result and Discussion
The structure of Jararacussin-I was solved at 2.48 Å resolution (Table I) by molecular-replacement methods using the MOLREP program28 and a model based on the atomic coordinates of the native protein C activator from the venom of Agkistrodon contortrix contortrix (ACC-C, PDB code: 2AIP).9
Table I. Data Collection and Refinement Statistics of Jararacussin-I
Values for the outermost resolution shell are given in parentheses.
Rmerge=∑hkl∑i|Ii(hkl)−〈I(hkl)〉|/∑hkl∑iIi(hkl), where Ii(hkl) is the intensity of the ith observation of reflection hkl and <I(hkl)> is the average over all observations of reflection hkl.
Rwork=∑hkl||Fobs|−|calc||/∑hkl|Fobs|, where Fobs and Fcalc are the observed and calculated structure-factor amplitudes, respectively. Rfree is Rwork calculated using 5% of the data that were omitted from refinement.
Jararacussin-I is comprised of 232 amino-acid residues folded in two domains each containing a six-stranded β-barrel and one short α-helix. As expected, the tertiary structure is highly conserved among SVSPs such as ACC-C9 and TSV-PA (a plasminogen activator from Trimeresurus stejnegeri venom10) and structural overlays result in r.m.s.d.s of 1.21 Å and 0.81 Å, respectively. The main differences are located at the loops surrounding the active site [residues 20–24, 42–47 72–86, 122–136, and 154–161, Jararacussin-I numbering; Fig. 1(A)]. The amino acid sequences comprising these loops are unique to each snake venom serine proteinase (SVSP) [Fig. 1(B)] and generate different glycosylation and charge profiles around the active-site pocket. TSV-PA, ACC-C, and Jararacussin-I are often referred to as glycoproteins; however, the effects of glycosylation with respect to their specificities are distinct. Among the three glycosylation sites (N38, N96A, and N148) present in ACC-C, only the one at position N148 is conserved in Jararacussin-I [Fig. 1(A)]. TSV-PA contains a glycosylation site at N17810 that is not conserved in Jararacussin-I [Fig. 1(A)]. It has been shown that glycosylation has no effect on TSV-PA activity,29 however in ACC-C, glycosylation plays a key role in macromolecular selectivity.9
Amino acid substitutions in the loops surrounding the active site significantly alter the surface charge distribution profile (Fig. 2) at the catalytic interface of Jararacussin-I in comparison to ACC-C and TSV-PA. Surface charge analysis demonstrated that Jararacussin-I exhibits a highly negatively charged surface around the active site [Fig. 2(A)], whereas in ACC-C the corresponding area is positively charged [Fig. 2(B)]. In addition, the differences in the loops surrounding the active site modifies the molecular topography of the catalytic interface, which along with the overall charge profile probably determines the macromolecular selectivity of Jararacussin-I.
The structural determinants for the mode of action of a plasminogen activator (TSV-PA, PDB ID: 1BQY) and a PC activator (ACC-C, PDB ID: 2AIP) have already been proposed by Parry et al.9 and Murakami and Arni,10 respectively. In TSV-PA, Phe 193 accounts for the high substrate specificity of TSV-PA and Asp97 is crucial for the plasminogenolytic activity. In ACC-C, the positive charge present on the interfacial surface and the carbohydrate moieties are important features that likely play crucial roles in PC recognition/binding/activation.
In this work, we postulate that the charge distribution profiles together with changes in the molecular topography around the catalytic interface are instrumental in defining macromolecular selectivity of TLEs.
Materials and Methods
Desiccated B. jararacussu crude venom (250 mg) was purchased from Serpentarium SANMARU, Taquaral, São Paulo, Brazil. Sephacryl S-100 16/60 and Benzamidine Sepharose 4 Fast Flow were obtained from GE Healthcare Life sciences. Molecular mass standards (GE Healthcare Life sciences) were bovine serum albumin (66 kDa); ovoalbumin (44 kDa), carbonic anhydrase (30 kDa), soybean trypsin inhibitor (20.1 kDa), and α-lactalbumin (14.4 kDa). All the other reagents were from Sigma-Aldrich, Brazil.
About 125 mg of B. jararacussu crude venom was suspended in 1.5 mL of Tris-HCl buffer containing 0.02M Tris; 0.15M NaCl, pH 8.0 and centrifuged at 10,000g for 10 min. The clear supernatant was applied to a 16 × 60 cm Sephacryl S-100 column previously equilibrated with a 0.02M Tris-HCl pH 8.0 buffer containing 0.15M NaCl, the absorption was monitored at 280 nm [Supporting Information Fig. S1(A)]. All fractions were analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) [Supporting Information Fig. S1(B)]. The above chromatographic procedure was repeated twice, totaling 250 mg of crude venom.
The fractions containing Jararacussin-I from molecular exclusion chromatography was pooled (total volume of ∼30 mL). This pool was applied to a benzamidine sepharose 4 fast flow column (high sub) (5 mL bed volume) using a super-loop at a flow rate of 0.5 mL/min. The column was pre-equilibrated with Tris-HCl 0.02M, NaCl 0.15M pH 8.0. The non-specifically bound proteins were eluted with the above buffer which additionally contained 0.5M NaCl. The specifically bound proteins were eluted by rapidly changing the pH from 8.0 to 3.0 using a glycine-HCl buffer. Proteins were eluted with a flow rate of 0.5 mL/min and fractions of 1 mL/tube were collected [Supporting Information Fig. S2(A)]. The pH of the eluted samples was immediately adjusted to pH 7.0 by adding a buffer containing 1M Tris pH 9.0. All fractions were analyzed by SDS-PAGE [Supporting Information Fig. S2(B)].
The Jararacussin-I sample was dialyzed against a 0.02M sodium acetate buffer pH 5.6 and was concentrated to 20 mg/mL in micro-concentrators (AMICON). Crystallization was performed by the hanging-drop vapor-diffusion method at 291 K using 24-well tissue-culture plates.30 The crystallization screen kits used were, Crystal Screen, Crystal Screen 2, Grid Screen Ammonium sulfate, and Grid Screen PEG 6000 (Hampton Research) and PEG suite (Qiagen). Typically, 1 μL drop of protein solution were mixed with 1 µL of the screening solution and equilibrated over a reservoir containing 0.5 mL of the latter solution. Initially, micro-crystals were obtained with 0.1M 2-(N-morpholino)ethanesulfonic acid (MES) pH 6.5, 0.01M zinc sulfate, and 25% (wt/vol) polyethylene glycol monomethyl ether (PEG) 550 MME. These conditions were optimized by changing the pH of the buffer and concentration of PEG and large single crystal were obtained when a 2 μL protein droplet was mixed with an equal volume of the reservoir solution containing 0.1M MES pH 6.7 and 30% PEG 550 MME.
Data collection and structure determination
The TLE crystal from B. jararacussu was directly flash-frozen in a 100 K nitrogen-gas stream and X-ray diffraction data were collected on the W01B-MX2 beamline at the Brazilian Synchrotron Light Laboratory (Campinas, Brazil). The wavelength of the radiation source was set to 1.458 Å and a MarMosaic 225 mm CCD detector was used to record the X-ray diffraction intensities. The data were indexed, integrated, and scaled using the DENZO and SCALEPACK programs from the HKL-2000 package.31 Molecular replacement was carried out using the MOLREP28 program and a model based on the atomic coordinates of native protein C activator from the venom of Agkistrodon contortrix contortrix (PDB code 2AIP).9
A. Ullah is the recipient of a TWAS doctoral fellowship.